# Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis

> **NCT01442779** · PHASE2 · COMPLETED · sponsor: **Texas Tech University Health Sciences Center** · enrollment: 18 (actual)

## Conditions studied

- Respiratory Tract Diseases
- Lung Diseases
- Lung Diseases, Interstitial
- Pulmonary Fibrosis

## Interventions

- **DRUG:** Interferon alpha oral lozenge

## Key facts

- **NCT ID:** NCT01442779
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442779, "Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01442779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*